You are here

  • Home
  • Archive
  • Volume 100, Issue 23
  • Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy (HCM): but what about ‘apical’ HCM?

Article Text

Article menu

See original article:

Download PDFPDF
PostScript
Correspondence
Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy (HCM): but what about ‘apical’ HCM?
  1. Amardeep Ghosh Dastidar,
  2. Jonathan Rodrigues,
  3. Chiara Bucciarelli-Ducci
  1. NIHR Bristol Cardiovascular Biomedical Research Unit, Bristol Heart Institute, University of Bristol, Bristol, UK
  1. Correspondence to Dr Amardeep Ghosh Dastidar, NIHR Bristol Cardiovascular Biomedical Research Unit, Bristol Heart Institute, University of Bristol, Bristol BS2 8HW, UK, amardeep.dastidar{at}me.com

https://doi.org/10.1136/heartjnl-2014-306762

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    To the Editor,

    We read with great interest the article by Ismail et al1 looking at the role of late gadolinium enhancement cardiac magnetic resonance (CMR) in the risk stratification of patients with hypertrophic cardiomyopathy (HCM). We would like to congratulate the authors for delineating the interesting findings that the amount of myocardial fibrosis was a strong univariable predictor of sudden cardiac death …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles